The tissue or glandular kallikreins (KLK) are members of a highly conserved multigene family encoding serine proteases that are central to many biological processes. The rodent KLK families are large, highly conserved and clustered at one locus. The human KLK gene family is clustered on chromosome 19q13.3-13.4, and until recently consisted of just three members. However, recent studies have identified up to 11 new members of the KLK family that are less conserved than their rodent counterparts. Using a Southern blot and sequence analysis of 10 BACs and cosmids spanning approximately 400 kilobases (kb) either side of the original KLK 60-kb locus, we demonstrated that these genes also lie adjacent to this. We have also clarified the position of several microsatellite markers in relation to the extended KLK locus. Moreover, from Southern blot analysis of the cosmids and BACs with a degenerate oligonucleotide probe to the histidine-encoding region of serine proteases, we have shown that there are no other serine protease genes approximately 400 kb centromeric and 220 kb telomeric of the extended locus. We performed an extensive analysis of the expression patterns of these genes by poly(A) ؉ RNA dot blot and reverse transcriptase-polymerase chain reaction analysis, and demonstrated a diverse pattern of expression. Of interest are clusters of genes with high prostate (KLK2-4) and pancreatic (KLK6 -13) expression suggesting evolutionary conservation of elements conferring tissue specificity. From these findings, it is likely that the human KLK gene family consists of just 14 clustered genes within 300 kb and thus is of a comparable size to the rodent families (13-24 genes within 310 and 480 kb, respectively). In contrast to the rodent families, the newest members of the human KLK family are much less conserved in sequence (23-44% at the protein level) and appear to consist of at least four subfamilies. In addition, like the rat, these genes are expressed at varying levels in a diverse range of tissues although they exhibit quite distinct patterns of expression.
Serine proteases are a group of protein-cleaving enzymes that contain a serine residue in their active site and play important roles in diverse physiological processes. The glandular or tissue kallikreins are a subgroup of serine proteases highly conserved across several species, that are involved in the post-translational processing of polypeptides to their bioactive or inactive forms, a function that underlies and is central to most biological events (1) . Tissue kallikrein (encoded by KLK1), 1 from which this family derives its generic name, processes kininogen to release (lys)-bradykinin, a multifunctional peptide involved in the regulation of local blood flow, sodium balance, inflammation, and cell proliferation in many tissues (2) . Other members of the KLK family include growth factor processing enzymes such as mouse epidermal growth factorbinding protein, ␥-nerve growth factor, and enzymes that generate vasoactive peptides such as the mouse pro-renin converting enzymes, ␥-renin, and rat tonin (3) (4) (5) . In man, the two other most well characterized enzymes, prostate-specific antigen, PSA (encoded by KLK3; Ref. 6) , and hK2 (encoded by KLK2; Ref. 7) , act on entirely different substrates. Nevertheless, each is involved in the selective cleavage of specific precursors to their bioactive or inactive forms (8) . These findings highlight the involvement of the KLK family in a number of different and complex enzymic pathways that underlie several important biological functions.
The wide range of potential functions of these enzymes is emphasized by their diverse, yet specific, tissue expression patterns. Whereas KLK2 and KLK3 are primarily expressed at high levels in the secretory epithelium of the prostatic ducts and have been implicated in normal prostatic function as well as in cancer progression (8) , tissue kallikrein, through its multifunctional roles, is involved in the (patho)physiology of the kidney, brain, and respiratory, gastrointestinal, and reproductive tracts (2) . This diverse functionality is underscored by the ubiquitous expression pattern observed for KLK1 in the rat (9) . Although a function has not yet been ascribed to the protein products of most other rat KLK genes, an indication of the tissue in which they will be functional is gained from their tissue expression patterns (9) . In man, the newly identified KLK serine proteases, Protease M/neurosin/zyme (10 -12) and normal epithelial cell-specific 1 (Nes1) 2 (13) , are highly ex-pressed in brain and breast tissue, and have been suggested to be involved in Alzheimer's disease and breast cancer, respectively (12) (13) (14) . Several other recently identified KLK-like serine protease genes have also been shown, at the RT-PCR level, to be expressed in a tissue-specific manner, which presumably indicates the tissues in which they will be biologically active (15) (16) (17) (18) (19) (20) . The KLK1, KLK2, and KLK3 genes are clustered within a region that spans 60 kb on chromosome 19q13.3-13.4 (21, 22) . This cluster maps to a position ϳ55.5 Mb from the p-telomere on the metric physical map of the chromosome and at the proximal end of 19q13. 4 . The larger size of the rat and mouse KLK gene families (13-24 genes) (23) (24) (25) , which are also clustered in one locus (23, 25, 26) , and the recent identification of a new KLK gene, KLK4 (prostase/KLKL1) (15, 21, 27) 25 kb downstream of the KLK2 gene (15, 21) , suggested that the human KLK gene family would be larger than previously thought. Indeed, Southern blot analysis of a human genomic library, using a monkey KLK cDNA with 92-95% homology to human KLK cDNAs (28) , indicated that there may be as many as 19 human KLK genes (29) . Furthermore, a number of KLKrelated serine protease gene sequences have been detected that lie telomeric to the original KLK locus, thus expanding the human KLK gene family (30) . However, the physical mapping of this locus has not yet been described and the definitive size of the family is not clear. In addition, the location of the various microsatellite markers in the KLK locus is not clear.
In this study, we have physically mapped the serine protease genes clustered at the KLK locus and defined the position of key microsatellite markers. We have also confirmed the order and orientation of the 10 putative new members of the human KLK family which span approximately 300 kb across the KLK locus on chromosome 19q13.4. We have further determined that no other serine protease genes are present within the regions surrounding the KLK locus. In addition, extensive gene expression studies have identified the most abundant sites of expression for these genes and a diverse tissue specificity of expression similar to the rodent KLK family. Also, phylogenetic analysis of the 14 serine proteases encoded by the KLK genes of this locus demonstrated the extent of divergence within the expanded family and suggested that there are at least four human KLK subfamilies.
EXPERIMENTAL PROCEDURES
Cosmid and BAC DNA Clones-Four cosmids (R32740, R31381, F22702, and R28781) and six BAC clones (BC772576, BC778306, BC33747, BC85745, BC349237, and BC892989), that spanned the classical KLK locus (KLK1-3) and approximately 400 kb either side of this region, were used in the following studies. Five hundred-ml cultures of Luria-Bertani medium supplemented with 20 g/ml kanamycin or 15 g/ml chloramphenicol, were inoculated with the BAC and cosmid clones, respectively, and incubated overnight at 37°C. DNA was then extracted using the alkaline lysis method, followed by RNase A digestion and ethanol precipitation.
Physical Mapping of the KLK Locus on Chromosome 19q-Twenty g of DNA from the set of 10 BAC and cosmid clones were digested overnight at 37°C with the restriction enzyme EcoRI, then separated electrophoretically on a 1% agarose gel. The gel was treated with 1.5 M NaCl, 0.5 M NaOH for 30 min to denature the DNA, rinsed briefly in distilled water, followed by a 30-min incubation in neutralization buffer (1.5 M NaCl, 0.5 M Tris-HCl, pH 7.4). The DNA was capillary blotted onto Hybond N TM nylon membrane (Amersham Pharmacia Biotech) overnight in 20 ϫ SSC then cross-linked to the membrane by ultraviolet irradiation. Membranes were hybridized with a 32 P-random labeled cDNA probe (Ambion), or a 32 P-end labeled gene-specific oligonucleotide probe (Table I) , or a 32 P-end labeled degenerate oligonucleotide probe to the highly conserved regions spanning either the catalytic histidine codon (GGTSCTSACAGCYGCCCAYTG; 16-fold degeneracy; S ϭ G or C, Y ϭ C or T) or the the catalytic serine codon (CAGIGGICCIC-CIGARTCAAC; 512-fold degeneracy; I ϭ inosine, r ϭ A or G) characteristic of serine proteases. Hybridization was performed overnight in ExpressHyb TM solution (CLONTECH) at 42 or 55°C for oligonucleotide and cDNA probes, respectively. Blots were washed in 1 ϫ SSC, 0.5% SDS up to 55°C, then exposed to x-ray film (AGFA Curix Ortho) at Ϫ80°C.
Computer Analysis of Chromosome 19 Sequences-Approximately 320 kb of draft sequence of chromosome 19q13.3-13.4 (available at the Lawrence Livermore National Laboratory and the DOE Joint Genome Institute website), beginning ϳ50 kb upstream of where two of the original KLK genes (KLK2-3) were localized and searched with the conserved peptide sequences spanning the catalytic histidine, aspartate, and serine residues of KLK serine proteases (WVLTAAHC, HDLMLLKL, and GDSGGPL; catalytic residue underlined). This was performed using the data base creating tool and the tBLASTN algorithm available at the Australian National Genome Information Service. In addition, the cDNA sequence of each of the serine proteases, KLK1 (accession number X13561), KLK2 (accession number S39329), KLK3 (accession number M26663), KLK4 (accession number AF113141), KLK5 1 (KLKL2, accession number AF135028), KLK6 (Protease M, accession number U62801), KLK7 (SCCE, accession number L33404), KLK8 (neuropsin, accession number AB009849), KLK9 (KLKL3, accession number AF135026), KLK10 (Nes1, accession number AF024605), KLK11 (TLSP, accession number AB012917), KLK12 (KLKL5, accession number AF135025), KLK13 (KLKL4,accession number AF135024), and KLK14 (KLKL6, accession number AF161221), was aligned against this genomic sequence using the BLASTN algorithm available at the National Center for Biotechnology Information website. BLASTN searches were also performed against the draft chromosome 19q13.3-13.4 sequence using microsatellite marker sequences between 272.77 and 276.46cR 3000 at interval D19S425-D19S418. Marker sequences used were: WI-9055 and M21896, U37672, stSG39975, sts-S39329, WI-20869, stSG30247, stSG32045, stSG1457, stSG3375, stSG372, sts-H71236, SGC35527, U37672, stSG30429, sts-AA028917, and L12214. The computer software DNAStar (Lasergene) was used to construct an EcoRI restriction enzyme map of this sequence. These data were then used in conjunction with the data obtained by physical mapping and the EcoRI map available at the Lawrence Livermore National Laboratory website to determine the exact position of each gene and to reconstruct a definitive EcoRI map of this region.
Sequence and Phylogenetic Analysis-Multiple alignment of deduced protein sequences was performed using the Eclustal tool available at RT-PCR, reverse transcriptase-polymerase chain reaction; kb, kilobase(s); PSA, prostate-specific antigen. 
EST clone AI935298 EcoRI/HindIII digest (750 bp) 5Ј-TGTTCACGCATTGCAGAGAGG-3Ј
Australian National Genome Information Service. The percentage identity between each of the 14 kallikreins was calculated using the Homologies tool on the Australian National Genome Information Service website. Phylogenetic studies were also performed via the Australian National Genome Information Service website. A distance matrix between the structures of the proteases was computed from the alignment using the Dayhoff program of the Phylip package (31) . The Neighborjoining method was then used to construct a tree from the distance matrix.
Poly(A)
ϩ RNA Dot Blot Analysis-For KLK1-4, 32 P-end labeled oligonucleotides were used to probe a CLONTECH Master blot containing poly(A) ϩ RNA from 50 different human tissues. Hybridizations were performed overnight in ExpressHyb TM solution (CLONTECH) at 42°C. For KLK6 -11 DNA fragments used in the poly(A) ϩ RNA dot blot analyses were obtained by RT-PCR using the primers detailed in Table II. RT-PCR was performed as described below for the screening of the cancer cell lines. Amplicons were purified using a PCR purification kit (Qiagen) and ligated into pGEM-T or pGEM-T Easy (Promega). DNA insert orientation was examined by sequencing and restriction enzyme digestion analysis. For KLK5 and KLK12-14, probes were generated from EST clones accession number W07551, accession numbers AI394679, AA002101, and AI935298 (Genome Systems Inc), respectively. Prior to radioactive labeling each construct was linearized before transcription using T7, T3, or SP6 RNA polymerase as appropriate to generate an antisense cRNA. Radiolabeled cRNA probes were generated from these clones by incorporation of [ 32 P]UTP (Geneworks) using a StripEz TM kit (Ambion) and hybridized, in Ultrahyb TM solution (Ambion), to a Multiple Tissue Expression array (CLONTECH) containing poly(A) ϩ RNA from 76 different human tissues and cell lines at 65°C overnight. All blots were washed in 0.1 ϫ SSC, 0.1% SDS up to 70°C, and signals were detected by exposure of the blot to x-ray film (AGFA Curix Ortho) for 1-7 days at Ϫ80°C. Control blots, containing DNA for each of the 14 kallikreins, were included in each hybridization to confirm the specificity of the radiolabeled probes.
Cell All cell lines were cultured in Dulbecco's modified Eagle's medium with 10% deactivated fetal calf serum and supplemented with 50 units/ml penicillin G and 50 g/ml streptomycin (CSL Biosciences) and incubated at 37°C with 5% CO 2 .
RT-PCR and Southern Blot Analysis-Total RNA was extracted from the cell lines using Trizol reagent (Life Technologies, Inc.) following the manufacturer's instructions. Two g of total RNA was reverse-transcribed into first-strand cDNA using Superscript II (Life Technologies, Inc.) in a 20-l reaction. The cDNA was subsequently diluted 5-fold and PCR was then performed in a reaction mixture containing 1 l of cDNA, 25 ng of each primer (Table II) , 0.1 mM dNTPs (containing dATP, dCTP, dGTP, and TTP), 2 l of 10 ϫ reaction buffer (Roche Molecular Biochemicals), 0.5 units of platinum Taq (Life Technologies), and sterile water to 20 l. The cycling conditions were 94°C for 5 min to activate the polymerase, followed by 35 cycles of 94°C for 1 min, 62-68°C for 1 min (depending on the target gene), 72°C for 1 min, and a final extension at 72°C for 7 min. Ten l of the PCR mixture was electrophoresed on a 2% agarose gel and visualized by ethidium bromide staining. The resulting amplicons were analyzed by Southern blot hybridization using digoxigenin 3Ј end-labeled oligonucleotide probes (Table I) P-end labeled degenerate oligonucleotide to the highly conserved region spanning the catalytic histidine of serine proteases. The blot was washed in 0.1 ϫ SSC, 0.1% SDS at 55°then exposed to film for 13 days. to the PCR primers used, in EasyHyb TM solution (Roche Molecular Biochemicals) overnight at 37°C. Washes were performed in 0.2 ϫ SSC, 0.1% SDS at 37°C. In addition, for each kallikrein cDNA primer pair at least one band of the predicted size was excised from a second 2% agarose gel following electrophoresis. The DNA recovered from each band was sequenced to determine the specificity of the PCR products.
Gene-specific Oligonucleotides-Gene-specific olionucleotides, used as probes in the genomic and/or RT-PCR Southern blot analyses (Table  I) were selected from regions with maximum dyshomology among the kallikreins based on a multiple sequence alignment of the 14 cDNAs.
The primers used in the PCR reactions (Table II) were designed to span at least one intron for each of the 14 genes. The primer pairs were chosen for their compatibility (i.e. no hairpin stem loops and similar melting temperatures) and were found to be specific for the gene in question upon BLAST analysis. In addition, the percent difference for each primer/probe as compared with those of all the 14 genes was calculated and found to range from 50 to 95%. The average percent divergence for the oligonucleotides used as probes in the Southern blot experiments was 70% whereas the average for the primers used in the PCR was 74%. 
RESULTS

Characterization of an Extended KLK Locus at Chromosome
19q13.4 -To determine if there were additional kallikrein genes surrounding the original KLK locus on chromosome 19q13.3-13.4, Southern blot analysis was performed using degenerate oligonucleotides to consensus sequences spanning the catalytic histidine and serine residues characteristic of serine proteases. A combination of 10 BACs and cosmids, which span 400 -500 kb on either side of the original KLK 60-kb locus, were digested with EcoRI and subsequently hybridized separately with each of the 32 P-labeled degenerate oligonucleotides. The autoradiograph resulting from hybridization with the degenerate "histidine" probe demonstrated positive signals within five of the BACs and cosmids (Fig. 1) . Three of these clones (BC33747, F22702, and R28781) contain the genes, KLK1-4 (21). However, a further two BACs (BC85745 and BC349237) also showed strong hybridization to these probes. These were not known to contain any serine protease genes. BC892989, which lies telomeric to the KLK cluster and the 4 clones centromeric to the cluster (R31381, R32740, BC778306, and BC772576) did not produce any positive signals even though the membrane was exposed for 13 days. The degenerate "serine" oligonucleotide probe could not be used successfully in these experiments, probably because of its degeneracy (512-fold). Thus, additional serine protease genes are only found within a region encompassed by BACs BC85745 and BC349237, and there are no other serine protease genes approximately 200 kb telomeric of BC349237 and 400 kb centromeric of the original KLK1-3 cluster.
In order to identify the serine protease genes which were detected using the degenerate probe described above, the same set of EcoRI-digested BACs and cosmids were examined using one or two gene-specific oligonucleotides or a cDNA probe to each of the KLK5-14 genes. The KLK5 probe hybridized to a 14.5-kb fragment on BC85745 (Fig. 2) . Positive signals were detected on BC85745 at 10 and 6.5 kb for KLK6 and at 15 kb for KLK7. A signal was observed for KLK8 on both BC85745 and BC349237 at 10.5 and 2 kb, respectively, and KLK9 was found to be located within three of the EcoRI fragments at 10, 3.5, and 1.8 kb on BC349237. Two bands at 18 and 10 kb were detected for KLK10 on BC349237 whereas only the 18-kb band was positive for KLK11. The remaining three KLK-like genes were all present on BC349237. KLK12 was present on an 18-kb band. Although only one signal (at approximately 5 kb) was detected for KLK13, this band represents two individual EcoRI fragments of 5.7 and 4.6 kb in size. The KLK14 cDNA probe hybridized to an 18-and a 12-kb band.
Concurrent with the physical mapping studies, computer analysis was performed on approximately 320 kb of draft genomic sequence spanning the KLK locus on chromosome 19q. hK1  hK2  hK3  hK4  hK5  hK6  hK7  hK8  hK9  hK10  hK11  hK12  hK13  hK14   hK1  100  67  62  34  31  37  37  36  35  31  36  27  37  39  hK2  100  77  34  33  41  38  38  36  33  36  27  41  40  hK3  100  34  33  36  37  36  34  31  34  26  40  38  hK4  100  45  36  43  35  31  29  35  25  35  40  hK5  100  36  38  38  38  33  39  25  38  39  hK6  100  38  42  36  34  38  32  46  45  hK7  100  40  33  36  36  28  38  41  hK8  100  42  40  42  33  41  44  hK9  100  33  49  29  37  40  hK10  100  35  31  34  35  hK11  100  30  41  40  hK12  100  31  30  hK13  100  43  hK14  100 To identify novel protease genes in this region, searches of the genomic sequence were performed using the consensus sequences spanning each of the histidine, aspartate, and serine residues necessary for the enzymatic activity of serine proteases. These searches identified 10 potential serine protease genes in addition to known kallikrein genes, KLK1-4. Further searches were then performed with the sequence for each of the KLK-like serine protease genes: Protease M (KLK6), SCCE (KLK7), neuropsin (KLK8), Nes1 (KLK10), TLSP (KLK11), KLKL2 (KLK5), KLKL3 (KLK9), KLKL4 (KLK13), KLKL5 (KLK12), and KLKL6 (KLK14), using the BLASTN algorithm. All 10 of these genes were identified within this sequence and were found to correspond to the genes identified from searches using the three serine protease consensus sequences. The genes were all located in a telomeric position with respect to the KLK2-4 genes. The KLK1 gene is located ϳ31 kb centromeric of KLK2-4 (21, 22) ; sequence data is not available for this region. Also, an EcoRI restriction map of the sequence contained within BACs BC85745 and BC349237 was constructed in silico. This map was used in conjunction with the physical mapping data and the EcoRI map available at the Lawrence Livermore National Laboratory website, to determine the exact position of each gene and to reconstruct a definitive EcoRI map of this region (Fig. 3) . The size of each of the bands identified by Southern blot analysis (Fig. 2 ) agreed with the in silico generated EcoRI fragment sizes. From the map, the order of the expanded KLK locus (according to the old nomenclature) is centromere-KLK1-KLK3-KLK2-KLK4-KLKL2-Protease M-SCCE-neuropsin-KLKL3-Nes1-TLSP-KLKL5-KLKL4-KLKL6-telomere (new nomenclature: centromere-KLK1-KLK3-KLK2-KLK4-to -KLK14-telomere). Analysis of the contiguous sequence indicated that KLK5 to KLK14 are transcribed telomere to centromere (Fig. 3) .
Clarification of the Position of Microsatellite Markers within the KLK Locus at Proximal 19q13.4 -To
clarify the order and position of the microsatellite markers within the KLK locus, microsatellite marker sequences were aligned against the chromosome 19q proximal 13.4 draft sequence data using the BLASTN algorithm. For this purpose, a data base of contiguous sequence was established using the resources available at the 
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Tissues arrayed on the membranes in panels A and B: A1, whole brain; A2, amygdala; A3, caudate nucleus; A4, cerebellum; A5, cerebral cortex; A6, frontal lobe; A7, hippocampus; A8, medulla oblongata; B1, occipital lobe; B2, putamen; B3, substantia nigra; B4, temporal lobe; B5, thalamus; B6, nucleus accumbeus; B7, spinal cord; C1, heart; C2, aorta; C3, skeletal muscle; C4, skeletal muscle; C5, bladder; C6, uterus; C7, prostate; C8, stomach; D1, testis; D2, ovary; D3, pancreas; D4 pituitary gland; D5 adrenal gland; D6, thyroid gland; D7, salivary gland; D8, mammary gland; E1, kidney; E2, liver; E3, small intestine; E4, spleen; E5, thymus; E6, peripheral blood leukocyte; E7, lymph node; E8, bone marrow; F1, appendix; F2, lung; F3, trachea; F4, placenta; G1, fetal brain; G2, fetal heart; G3, fetal kidney; G4, fetal liver; G5, fetal spleen; G6, fetal thymus; G7, fetal lung; H1, yeast total RNA, 100 ng; H2, yeast tRNA, 100 ng; H3, Escherichia coli rRNA, 100 ng; H4, E. coli DNA, 100 ng; H5, Poly r(A) 100 ng; H6, human C 0 t-1 DNA, 100 ng; H7, human DNA, 100 ng; H8, human DNA, 500 ng. Tissues arrayed on the membranes in panels C and D: A1, whole brain; A2, cerebellum, left; A3, substantia nigra; A4, heart; A5, esophagus; A6, colon; A7, kidney; A8, lung; A9, liver; A10, leukemia, HL-60; A11, fetal brain; A12, yeast total RNA; B1, cerebral cortex; B2, cerebellum, right; B3, accumbens nucleus; B4, aorta; B5, stomach; B6, colon, descending; B7, skeletal muscle; B8, placenta; B9, pancreas; B10, HeLa S3; B11, fetal heart; B12, yeast tRNA; C1, frontal lobe; C2, corpus callosum; C3, thalamus; C4, atrium, left; C5, duodenum; C6, rectum; C7, spleen; C8, bladder; C9, adrenal gland; C10, leukemia, K-562; C11, fetal kidney; C12, E. coli rRNA; D1, parietal lobe; D2, amygdala; D3, pituitary gland; D4 atrium, right; D5 jejunum; D7, thymus; D8, uterus; D9, thyroid gland; D10, leukemia MOLT-4; D11, fetal liver; D12, E. coli DNA; E1, occipital lobe; E2, caudate nucleus; E3, spinal cord; E4, ventrical, left; E5, ileum; E7, peripheral blood leukocyte; E8, prostate; E9, salivary gland; E10, Burkitt's lymphoma, Raji; E11, fetal spleen; E12, Poly r(A); F1, temporal lobe; F2, hippocampus; F4, ventrical, right; F5, ilocecum; F7, lymph node; F8, testis; F9, mammary gland; F10, Burkitt's lymphoma, Daudi; F11, fetal thymus; F12, human C 0 t-1 DNA; G1, cerebral cortex; G2, medulla oblongata; G4 interventricular septum; G5, appendix; G7, bone marrow; G8, ovary; G10, colorectal adenocarcinoma, SW480; G11, fetal lung; G12, human DNA 100 ng; H1, pons; H2, putamen; H4, apex of heart; H5, colon, ascending; H7, trachea; H10, lung carcinoma, A549; H12, human DNA 500 ng.
Australian National Genome Information Service website. Marker sequences between 272.77 and 276.46cR 3000 at interval D19S425-D19S418 on chromosome 19 were aligned with the nucleotide sequence within the data base. The data obtained from these searches was used to re-evaluate the order and presence of these markers within the region of the KLK locus (Fig. 3) . Markers WI-9055 and M21896, previously recognized as partial KLK3 sequence, as well as U37672 (previously unknown) were all found to lie within the KLK3 sequence on cosmid F25479. The two markers previously identified as partial KLK1 sequence, stSG39975 and sts-S39329, are actually partial sequences of the KLK2 gene and were found within the sequence of R33359 which overlaps cosmid F22702 at this location. The marker, WI-20869, recognized as KLK6 partial sequence, was confirmed to lie within the KLK6 coding sequence on BC85745. Similarly, stSG30247 was shown to lie within the KLK10 sequence on BC349237. In contrast, none of the remaining microsatellite markers listed as being located in the interval D19S425-D19S418 were detected within the available genomic sequence of the extended KLK locus. These markers are stSG32045 (EST), stSG1457 (␤-Electron transfer flavoprotein), stSG3375 (OTK18 mRNA), stSG372 (CD33 antigen), sts-H71236 (EST), SGC35527 (granulocyte colony stimulating factor-induced gene), U37672 (unknown), stSG30429 (EST), sts-AA028917 (EST, highly similar to zinc finger protein 91), L12214 (unknown). Prior mapping work shows genes CD33 and ETFB to be distal to the KLK locus by ϳ40 and ϳ250 kb, respectively.
Divergence of Serine Protease Genes within the Extended KLK Locus-Protein alignments were performed to establish the degree of similarity and divergence of the 14 serine protease genes located within the expanded KLK locus. The percentage homology between the proteins encoded by the 14 KLK genes was also calculated (Table III) . The classical KLK family members, hK1, 3 hK2 and PSA (encoded by KLK1, KLK2, and KLK3, respectively), display a high degree of homology (62-77% identity) at the protein level. hK4, is less similar with only 34% identity to PSA. As shown in Table III , hK4 possesses a similar degree of homology to the more recently identified serine proteases hK5-14 (25-45%) as it does to PSA. Similarly, the degree of homology between the protease groups, hK5-14 and hK1-3, ranges from 26 to 41%. Phylogenetic analysis of the 14 protein sequences produced similar results to the homology studies (Fig. 4) . The phylogenetic tree demonstrated that hK1, hK2, and PSA lie on one branch, as do hK4, hK5, and hK7. The two serine proteases, hK10 and hK12, were clustered on a third branch while hK9 and hK11 were found on a fourth branch. However, the remaining four members (hK6, hK8, hK13, and hK14) were located around the base of the tree. Due to the low branch numbers assigned to these four kallikreins, it is difficult to precisely determine their degree of divergence from the family as a whole. Nevertheless, the high branch numbers observed overall suggest that this expanded family of human kallikreins consist of at least four subfamilies. mRNA Expression Patterns-To establish a comprehensive pattern of expression for the 11 KLK genes, KLK4 -14, as compared with that known for KLK1-3, arrays containing poly(A) ϩ RNA from either 50 or 76 different human tissues and cell lines were screened using 32 P-labeled probes to each of the 14 KLK serine protease genes. Examples of the autoradiographs obtained are shown in Fig. 5 and a summary of the expression levels is shown in Table IV . The expression patterns observed for KLK1-4 were as previously reported, where KLK1 was detected in the kidney, pancreas, and salivary gland while KLK2-4 were present only within the prostate (27, 32, 33) . High expression of the KLK10 gene was observed in the pancreas and moderate expression in the esophagus, duodenum, trachea, and colorectal adenocarcinoma. Low expression was seen in tissues such as the liver, kidney, ovary, testis, prostate, and salivary gland. High expression of KLK11 was also de- 3 Kallikrein family protein nomenclature used here is that described by Berg et al. (3), e.g. protein hK1 corresponds to gene KLK1. tected in the pancreas. Moderate expression of KLK11 was observed in the heart, salivary gland, stomach, liver, and skeletal muscle, while low expression was observed in most of the remaining tissues represented on the blot. Of interest, is the overall high expression of nearly all of these new KLK genes in the pancreas, particularly KLK6 to KLK13. Furthermore, moderate expression was observed for several genes in the salivary gland, esophagus, trachea, brain, gastrointestinal, and reproductive organs. In addition, RT-PCR was performed using total RNA extracted from a number of different transformed and cancer cell lines as well as normal and cancer tissues. To increase the sensitivity of detection, Southern blot analysis using genespecific oligonucleotide probes was performed on the PCR products as shown in Fig. 6 and summarized in Table V . To confirm the specificity of the PCR for each of the 14 genes, bands of the predicted size were sequenced and found to correspond to the gene of interest (see Table V) . From these results, it can be seen that each gene displays a distinctive expression pattern with several genes (KLK1, KLK6, KLK7, KLK9, KLK10, KLK11, KLK13, and KLK14) being expressed in a broad range of tissues/cell lines whereas other genes (KLK2-5, KLK8, and KLK12) are less widely expressed. Of interest is the high expression of many of the newer KLK genes (KLK5-14) in keratinocyte (HaCAT), ovarian (OVCAR-3 and PEO1), breast (T47D), and endometrial (KLE) cancer cell lines. In addition, all genes (except for KLK12) appear to have varying levels of expression in one of the four prostate cancer cell lines. Furthermore, several of these genes are moderately expressed in the salivary gland and kidney. Additional bands were observed for several of the genes being examined. Some of these alternate bands were sequenced and found to represent variants of the gene in question (data not shown). Similarly, other studies have identified alternatively spliced transcripts for these new KLK genes (19) .
DISCUSSION
The tissue kallikrein genes, particularly those in rodents, represent a distinctive family of a large number of genes, which are highly conserved in sequence and genomic organization. Nevertheless, the encoded enzymes exhibit specific tissue expression patterns and diverse biological functions. We have now determined that the size of the human KLK gene family, like its rodent counterparts, is large and it is likely to consist of 14 genes. Physical mapping of these genes at chromosome 19q13.4 concurs with recent computer analysis of draft sequence data of this region (30) . The tissue-specific patterns of expression observed for these 14 genes shows, again like rodents, a diverse expression profile for individual members of the family. Of interest, however, is that the human family has diverged further in sequence.
The rodent KLK families are very large with 13 genes in the rat and 24 genes in the mouse (23) (24) (25) and both cluster to one chromosomal loci (23, 25, 26) . The original human KLK family (KLK1-3), also clustered to one loci (21, 22) , has a high degree of similarity to the rodent family with 65-72% identity at the nucleotide level. Due to the similarity between these KLK families and the previous report by Murray et al. (29) , which proposed the existence of up to 19 human KLK genes by screening human genomic DNA with a monkey cDNA, we began the search for new members of the human KLK family. In addition, previous studies placed the genes encoding the serine proteases Protease M and Nes1 (KLK6 and KLK10 respectively), on chromosome 19q in a region to which the original kallikreins, KLK1-3, also map (10, 13) .
Our initial studies involving Southern blot analysis identified several potentially novel serine protease genes within the surrounding regions of chromosome 19q. Further investigation of these results identified five published serine protease genes (previously named Protease M, Nes1, TLSP, SCCE, and Neuropsin) on the BACs and cosmids containing the human KLK genes, KLK2-4. All five genes were detected telomeric to KLK4 and thus were considered to be candidates for new members of the human KLK family. Furthermore, several other KLK-related sequences, KLK5, KLK9, and KLK12-14, were also physically mapped to 19q13.4. This confirmed the recently published data identifying the position of these genes on chromosome 19, by computer analysis (30) . In addition, as the data obtained by Southern blot analysis with a degenerate probe to the histidine-encoding region of serine proteases, detected unaccounted for signals only within the two BACs adjacent to the classical KLK locus (BC85745 and BC349237) and no signal from DNA, both telomeric to these two BACs or centromeric to the original KLK cluster, it would appear that there are only 10 additional serine protease genes within the surrounding regions of the classical KLK locus. In accordance with our data, the next gene telomeric from KLK14 (KLK-L6) is an unrelated gene, OB-BP-like, and encodes a putative leptinbinding protein (34) . Accordingly, although sequence is not yet available for the region centromeric to KLK1, it is likely the complete KLK locus has now been identified. FIG. 6 . Expression pattern analysis by RT-PCR. Analysis was performed on total RNA isolated from the displayed cell lines and tissues using the primers listed in Table II . RT-PCR products were transferred to nylon membranes and probed by Southern blot analysis using digoxigenin-labeled oligonucleotide probes (Table I) internal to the PCR primers used. SG, salivary gland.
Comparison of the rat KLK gene sequences indicates concerted evolution of the family that results in sequence homogenization of all family members (35) . In addition, there is a clear conservation of genomic organization with 5 coding exons for all KLK genes, although some of the newer family members have additional exons containing 5Ј-untranslated sequences (6, 7, 10, 13, 15-21, 23, 27) . Characterization of the mouse and rat KLK genes showed that nucleotide sequence identity exceeds 85% and extends throughout the coding regions, introns, and gene flanking sequences (23, 24, 35) . The first characterized human KLK family members, KLK1-3, also show high sequence homology, at both the nucleotide and protein level (62-77%) (6, 7, 23, 32) . However, in man the level of homology drops sharply for kallikrein genes telomeric of KLK1-3. The next closest gene along the locus, KLK4 (15, 21) , is 34% identical to KLK3 (15, 21, 27) . Similarly, as reported here and by others, the newer members of the family (KLK5-14) are less conserved with 25-49% similarity at the protein level, both between each other and with respect to KLK1-KLK4 (10, 13, (15) (16) (17) (18) (19) (20) . This divergence was also evident from our phylogenetic analysis. The degree of divergence seen within the human KLK family tree suggests that there are a number of subgroups within this species. The mouse Klk and original human KLK gene families were shown to lie in syntenic regions on chromosomes 7 and 19q, respectively (21) (22) (23) . Of interest, the putative mouse orthologue of one of the newer human KLK genes, KLK8 (neuropsin), also maps to this region on chromosome 7 (36) .
Analysis of microsatellite markers within the KLK locus showed that the current order needed to be revised. Alignment of each of the markers with the genomic sequence for chromosome 19q revealed that a number of the genes listed were in fact not found within the sequence available spanning the KLK locus. Nevertheless, those markers representative of partial KLK2, KLK3, KLK6, and KLK10 gene sequences were indeed detected within the genomic sequence. Thus, the listing of the microsatellite markers within the KLK locus has now been further clarified.
Poly(A) ϩ RNA dot blot analysis indicated the prostate-restricted expression of KLK2-4 and abundant expression of KLK6 -13 in pancreas. Of interest, in an analogous fashion to the mouse and rat clustered Klk/KLK genes which are predominantly expressed in the salivary gland (9, 23), KLK2-4 are clustered together within the human locus as are KLK6 -13. Furthermore, in man the two genes displaying high expression in the testis/mammary gland and brain/bone marrow/fetal liver, KLK5 and KLK14, respectively, are located either side of the cluster of pancreatic-expressed genes. As the KLK5 gene lies adjacent to the KLK2-4 cluster, also found in a hormonedependent tissue, these four genes may also share common transcriptional control elements. As has been suggested for the rat kallikreins (9, 24, 35) , this clustering of genes having common restricted expression patterns likely indicates evolutionary conservation of elements conferring tissue specificity such as duplicated promoter elements or a locus control region. Whether KLK transcriptional control in man is conferred through either or both of these elements is not yet known. Certainly our phylogenetic studies indicate that the human kallikreins have diverged to a much greater extent than the comparably sized rodent families. This observation may indicate that duplicated promoter elements would not be expected to have survived the apparent evolutionary pressure to diverge in man or, alternatively, may account for variations in expression patterns. Of interest, a pancreatic-specific-like sequence, similar to that identified in other rat pancreatic serine proteases (37, 38) , has been identified in the promoter of the rat, mouse, and human KLK1 genes (24) . In contrast, duplicated promoter regions have already been identified in the KLK2 and KLK3 genes (39, 40) . In addition, although expression profiles of rat kallikreins show that individual genes are expressed in diverse tissue-specific patterns there is still high conservation of potential transcriptional regulatory regions (24, 25) .
Our RT-PCR analysis of the cell line expression patterns of KLK5-14 indicated that most of these genes display significant expression in keratinocytes, breast, ovarian, and endometrial cancer cell lines and in salivary gland tissue and a salivary gland cell line. Expression of these KLKs in cancer-derived and transformed cell lines is not surprising, and concurs with other studies (10, 11, 13-21, 27, 34, 43) , as proteases are well known to aid in malignant processes such as invasion, metastasis, and proliferation (41, 42) . It will be of interest to determine whether any of the kallikreins are up-regulated in tumors and the role of these proteolytic enzymes in tumor progression.
Although the enzymic function of these newer kallikrein enzymes is yet to be elucidated, an indication of the tissue in which they will be functional may be gained from the patterns of expression noted above. From several in vitro biochemical studies, PSA and hK2 are known to degrade extracellular matrix proteins and PSA degrades the insulin-like growth factorbinding protein 3 to regulate the bio-availability of insulin-like growth factor 1; a key factor in cancer cell proliferation (8, 44) . The hK2 enzyme is likely the physiological activator of PSA (8) and hK2 can also activate urokinase plasminogen activator (45) , another key enzyme in matrix degradation, demonstrating that involvement in an enzymic cascade may also be an important function of this family of enzymes. Both PSA and hK2 are useful diagnostic and prognostic markers in prostate and breast cancer (8, 34) . Thus, many of the newer members of the KLK family which are all expressed in a variety of cancer cell lines may have similar functional roles in these diseases. Similarly, other new KLK members, which are highly expressed in skin and brain, have been suggested to play important roles in the (patho)physiology of these organs (12, 46 -48) .
The high pancreatic and gastrointestinal tract expression of several KLK genes may also prove to be of significance since tissue kallikrein has already been shown to play a role in the (patho)physiology of these tissues (2, 49) . In summary, we have physically mapped the KLK locus, providing a definitive fine map of this region at 19q13.4 and have further clarified the size and expression patterns of the extended human KLK gene family. Our tissue mRNA expression studies indicate KLK expression can be largely delineated between those having prostate restricted expression (KLK2-4) and those having abundant pancreas expression (KLK6 -13). These profiles suggest evolutionary conservation of elements conferring tissue specificity such as duplicated promoter elements and locus control regions. Future studies will be directed at characterizing these elements and in elucidating the roles of kallikrein serine proteases in human biology and disease.
